Antibiotice Ia Capital Reinvestment Ratio

Latest as of June 2026: 2.63x

Antibiotice Ia capital reinvestment ratio. Antibiotice Ia (ATB) has a Capital Reinvestment Ratio of 2.63x as of June 2026, meaning it reinvests 3% of its operating cash flow (RON18.71 Million) in capital expenditures (RON49.25 Million). Check how aggressively does Antibiotice Ia reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

2.63x
Capex / Operating Cash Flow

Operating Cash Flow

RON18.71 Million
RON

Capital Expenditures

RON49.25 Million
RON

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Antibiotice Ia (2022–2025)

Capital reinvestment ratio of Antibiotice Ia from 2022 to 2025. This chart tracks Antibiotice Ia's Capital Reinvestment Ratio across 4 annual periods. Also explore net asset momentum of Antibiotice Ia to track the company's year-over-year net asset growth rate.

Antibiotice Ia Capital Reinvestment Ratio by Year (2022–2025)

Antibiotice Ia capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see Antibiotice Ia operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (RON) Capital Expenditures YoY Change
2025 1.97x RON72.44 Million RON142.61 Million ▲ +61.3%
2024 1.22x RON95.15 Million RON116.16 Million ▲ +52.5%
2023 0.80x RON122.46 Million RON98.04 Million ▲ +132.2%
2022 0.34x RON115.66 Million RON39.88 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow